20.510 articles found

Evaluating the Link Between Dopaminergic Treatment, Gait Impairment, and Anxiety in Parkinson's Disease.

Ehgoetz Martens KA, Ellard CG, Almeida QJ.

Mov Disord Clin Pract · 2016-01-09

DOI: 10.1002/mdc3.12298PMID: 30363509

Treatment Preferences at the End-of-Life in Parkinson's Disease Patients.

Li W, Ng HL, Li W, Piano AN, Karim SA, Tay KY, Au WL, Tan LC.

Mov Disord Clin Pract · 2016-01-09

DOI: 10.1002/mdc3.12313PMID: 30363514

Orthostatic tremor: Clinical, electrophysiologic, and treatment findings in 184 patients.

Hassan A, Ahlskog JE, Matsumoto JY, Milber JM, Bower JH, Wilkinson JR.

Neurology · 2016-01-08

DOI: 10.1212/wnl.0000000000002328PMID: 26747880

Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.

Xu X, Huang J, Li J, Liu L, Han C, Shen Y, Zhang G, Jiang H, Lin Z, Xiong N, Wang T.

Cell Prolif · 2016-01-08

DOI: 10.1111/cpr.12229PMID: 26748765

CART modulates the effects of levodopa in rat model of Parkinson's disease.

Upadhya MA, Shelkar GP, Subhedar NK, Kokare DM.

Behav Brain Res · 2016-01-08

DOI: 10.1016/j.bbr.2015.12.031PMID: 26771081

Parkinson's disease: fetal cell or stem cell derived treatments.

Astradsson A, Aziz T.

BMJ · 2016-01-07

DOI: 10.1136/bmj.h6340PMID: 26743154

The Human Experience with Intravenous Levodopa.

Siddiqi SH, Abraham NK, Geiger CL, Karimi M, Perlmutter JS, Black KJ.

Front Pharmacol · 2016-01-06

DOI: 10.3389/fphar.2015.00307PMID: 26779024

Ubiquitin phosphorylation in Parkinson's disease: Implications for pathogenesis and treatment.

Chin LS, Li L.

Transl Neurodegener · 2016-01-06

DOI: 10.1186/s40035-015-0049-6PMID: 26740872

Effects of soybean ingestion on pharmacokinetics of levodopa and motor symptoms of Parkinson's disease--In relation to the effects of Mucuna pruriens.

Nagashima Y, Kondo T, Sakata M, Koh J, Ito H.

J Neurol Sci · 2016-01-06

DOI: 10.1016/j.jns.2016.01.005PMID: 26810548

Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia.

Tamtè M, Brys I, Richter U, Ivica N, Halje P, Petersson P.

J Neurophysiol · 2016-01-06

DOI: 10.1152/jn.00868.2015PMID: 26740532

Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias.

Jin X, Schwabe K, Krauss JK, Alam M.

Exp Brain Res · 2016-01-02

DOI: 10.1007/s00221-015-4532-1PMID: 26724931

Continuous L-DOPA secretion by AAV gene therapy to improve the treatment of Parkinson's disease

Antunes ASLM.

· 2016-01-01